Hussman Strategic Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.04M	Buy	52,500 +21,000	+67%	+$1.64M	0.87%	6
2025 Q4	$2.49M	Buy	+31,500	New	+$2.73M	0.6%	51
2025 Q1	–	Sell	-31,500	Closed	-$1.74M	–	240
2024 Q4	$1.74M	Buy	+31,500	New	+$1.81M	0.51%	79
2024 Q3	–	Sell	-42,000	Closed	-$2.67M	–	226
2024 Q2	$2.67M	Buy	42,000 +10,500	+33%	+$682K	0.74%	43
2024 Q1	$2.18M	Buy	+31,500	New	+$1.9M	0.51%	76
2021 Q3	–	Sell	-30,400	Closed	-$1.07M	–	319
2021 Q2	$1.07M	Hold	30,400	–	–	0.22%	174
2021 Q1	$1.1M	Hold	30,400	–	–	0.23%	170
2020 Q4	$883K	Sell	30,400 -5,100	-14%	-$146K	0.23%	165
2020 Q3	$1M	Hold	35,500	–	–	0.26%	153
2020 Q2	$1.15M	Hold	35,500	–	–	0.29%	134
2020 Q1	$1.45M	Hold	35,500	–	–	0.39%	99
2019 Q4	$2.19M	Hold	35,500	–	–	0.7%	46
2019 Q3	$2.59M	Buy	35,500 +10,500	+42%	+$786K	0.73%	46
2019 Q2	$2.06M	Buy	25,000 +11,500	+85%	+$818K	0.57%	73
2019 Q1	$952K	Sell	13,500 -3,500	-21%	-$206K	0.23%	156
2018 Q4	$765K	Hold	17,000	–	–	0.18%	173
2018 Q3	$961K	Buy	+17,000	New	+$1.04M	0.28%	126